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Abstract
Background:  A number of previous studies have suggested that the Japanese have few
opportunities to participate in medical decision-making, as a result both of entrenched physician
paternalism and national characteristics of dependency and passivity. The hypothesis that Japanese
patients would wish to participate in treatment decision-making if adequate information were
provided, and the decision to be made was clearly identified, was tested by interview survey.
Methods: The subjects were diabetic patients at a single outpatient clinic in Kyoto. One of three
case study vignettes (pneumonia, gangrene or cancer) was randomly assigned to each subject and,
employing face-to-face interviews, the subjects were asked what their wishes would be as patients,
for treatment information, participation in decision-making and family involvement.
Results: 134 patients participated in the study, representing a response rate of 90%. The overall
proportions of respondents who preferred active, collaborative, and passive roles were 12%, 71%,
and 17%, respectively. Respondents to the cancer vignette were less likely to prefer an active role
and were more likely to prefer family involvement in decision-making compared to non-cancer
vignette respondents. If a physician's recommendation conflicted with their own wishes, 60% of the
respondents for each vignette answered that they would choose to respect the physician's opinion,
while few respondents would give the family's preference primary importance.
Conclusions: Our study suggested that a majority of Japanese patients have positive attitudes
towards participation in medical decision making if they are fully informed. Physicians will give
greater patient satisfaction if they respond to the desire of patients for participation in decision-
making.
Background
The current dominant ideology of health care in Western
countries supports the active participation of patients in
decision-making, but this is less accepted in Japan where
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physician paternalism remains dominant [1]. Recent
studies conducted in Japan have produced contradictory
results as regards patients' desire for information and for
self-determination. Kubo and Ishizaki reported that a
majority of Japanese patients thought the physician
should make the final decision [2,3], while Asai and Toy-
okawa found Japanese patients were dissatisfied with the
current situation and wanted to actively participate in
decision-making regarding their treatment [4-6].
Medical choices include two elements: problem-solving
(PS) and decision-making (DM) [7]. PS involves identifying
the single or most correct solution to a problem, which
usually requires expertise, and in which patient involve-
ment can only have a limited role. By contrast, DM
involves making a choice, often involving trade-offs, from
a number of possible alternatives. Such processes as mak-
ing diagnoses and identifying treatment options, risks,
and benefits, and the outcome probabilities associated
with each option, belong to PS tasks, while those of deter-
mining overall utilities and tailoring to patient idiosyncra-
cies belong to DM tasks [7-9].
Although DM and PS tasks are not always mutually exclu-
sive, the distinction between them is important in the
context of understanding the expectations and limits of
patient autonomy. When patients are presented with PS
tasks, they are usually happy to hand these over to
"experts". However, this response does not mean that
such patients do not, nevertheless, wish to participate in
decision making when the PS tasks are completed and
provided decision points for care or treatment are clearly
identified. Some previous studies in Japan, which have
sought to ascertain patients' desire for autonomy [2,3],
have failed to distinguish between PS and DM tasks. As a
result, the patients' desire for participation in decision
making may have been underestimated. However,
because there is no room for PS tasks in cases of terminal
illness, similar studies on advanced directives may possi-
bly have successfully revealed the level of patients' desire
for autonomy [5]. However, no study of patients' desire
for participation in decision making that explicitly dis-
criminates between PS and DM tasks has yet been con-
ducted in Japan.
True self-determination cannot be achieved without
knowledge of the disease and its treatment options. Japa-
nese patients have limited opportunities for self-determi-
nation because the information given them is
unsatisfactory from several points of view. Firstly, Japa-
nese physicians tend to think that patients in general will
not understand and that therefore it is futile, or worse, to
give difficult medical information; they have expressed
concern that imparting complicated medical information
is likely to result in unnecessary anxiety and confusion
[10]. Secondly, it is a common practice among Japanese
physicians to withhold 'bad news' from patients and,
especially in the case of cancer, to inform family members
first, in the belief that this is the kindest way to proceed
[11-14]. The diagnosis is revealed to the family, who then
make the decision as to whether or not to inform the
patient. Many patients do not like to ask for withheld
information, even when they want to be told the truth
[12].
In countries such as Japan, where the patient's family is
often informed first, and therefore plays an important role
in decision making, the degree of patient involvement in
medical decision making is very much controlled by fam-
ily members. Some physicians consider the family-physi-
cian relationship more important than the physician-
patient relationship [14]. Ruhnke et al. surveyed the atti-
tudes of Japanese physicians and patients to ethical deci-
sion making and patient autonomy, and found that 80%
of physicians and 65% of patients agreed that the doctor
should report the diagnosis of incurable cancer to a
patient's family first, and should also let them decide
whether or not the patient was to be informed [15]. In the
same survey, only 24% of Japanese patients agreed with
disclosure of a diagnosis of incurable cancer to a patient,
if the patient's family did not want the patient to be told.
Existing models for patient autonomy [16-19] envision a
dyadic interaction between patient and physician, and so
may not be suitable for the situation in Japan. It would be
interesting to know to what extent the family-patient rela-
tionship in Japan is conflictual or supportive, and how it
affects the clinical relationship. As a first step, the pre-
ferred roles of Japanese patients in medical decision-mak-
ing, vis-a-vis both physicians and family members, need
to be clarified.
This study was planned to investigate the following ques-
tions:
1. Would patients want to participate in treatment deci-
sion making if complete information regarding their diag-
nosis and treatment options were given, and if the
decisions to be made were clearly identified?
2. What are the factors (e.g. patients' characteristics, sever-
ity of disease) that most affect patients' desire to partici-
pate in DM?
3. What roles do patients want physicians and family
members to play in treatment decisions?BMC Family Practice 2004, 5 http://www.biomedcentral.com/1471-2296/5/1
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Methods
Subjects
The subjects were patients with type 2 diabetes mellitus
attending Kyoto Preventative Medical Center, a consulting
clinic attached to a health-screening center foundation in
Kyoto City. With their doctors' permission, we recruited a
sample from among patients cared for by two physicians
and who attended the clinic between 14 February, 2000
and 6 May, 2000. The study took the form of an interview
survey. Patients seeking treatment at the clinic on the days
the interviewer was present were randomly approached by
one of the authors (MS). The purpose of the study was
explained and they were asked to participate. Patients
were also told that they had the right to refuse to partici-
pate in any portion of the interview and that their refusal
would not cause them disadvantages. This was all
expressed to eligible patients in written form. Patients
who agreed were interviewed face-to-face and the subjects'
responses were tape-recorded.
We did not seek Institutional Review Board (IRB)'s
approval for this study for the following reasons. In 2000,
when this study was designed, Japan's IRBs did not
demand ethical review for research involving interview
surveys, and the Ethics Review Committee of Kyoto Uni-
versity, at that time, reviewed only research protocols for
clinical trials. Given these circumstances, we opted for an
unofficial discussion on the ethical issues pertaining to
this study. Members of this discussion included faculty in
the Department of General Medicine and Clinical Epide-
miology, Kyoto University. This discussion concluded
that inherent risks could be controlled by ensuring partic-
ipants' voluntariness and data confidentiality. The
research protocol was proposed to Kyoto Preventative Med-
ical Center where this study was conducted and was
approved by the institution.
Questionnaire contents
The questionnaire details are shown in the appendix.
Original vignettes were written in Japanese and all inter-
views were conducted in Japanese. Prior to the interview,
the subjects were given a brief outline of the study and
were assured of the confidentiality of their responses. The
introductory section of the questionnaire covered socio-
demographic information, including age, sex, marital sta-
tus, employment status, family members, and years of
schooling.
The three vignettes, presenting pneumonia, gangrene and
cancer, represented different levels of severity of illness
and difficulty in decision-making. In these terms, pneumo-
nia is mild disease; gangrene a severe and high risk disease,
but with benefits of treatment which are relatively easy to
understand; and cancer a severe life-threatening disease.
One of the vignettes was randomly allocated to each sub-
ject, using lots. First, the allocated vignette was presented
to the subject, who was then asked by the interviewer
whether he/she would consult a physician (Question A).
After the diagnosis for each vignette was revealed, the sub-
ject's knowledge of treatment options was explored
(Question B). The interviewer then provided information
about diagnosis, treatment options, and prognosis,
including risks, benefits and outcome probability, so that
the subject without prior knowledge or PS capacity could
participate in associated decision making. The subject was
then asked questions regarding his/her anticipated desire
for treatment information, personal DM participation,
family involvement in decision making, and knowledge
of the probability of various treatment outcomes (from C
through G in the appendix).
Statistical analysis
Normally distributed variables were compared using Stu-
dent's t-test and one-way ANOVA. Responses to questions
on the patient's desire for medical information (Question
C-1 through C-6) were coded on a scale of 1 to 3, with 1
representing not at all; 2, partially; and 3, fully. Ordinal
variables were compared using the Kruscal-Wallis test. The
patients' preferred roles in decision making were classified
into three categories using similar criteria to those used in
previous studies [7,20], as follows: "active" if the answer
to  Question E ('Who should decide which treatment
option should be selected?') was "myself alone" or
"myself and my family alone"; "passive" if the answer was
"the doctor and my family alone" or "the doctor alone";
and "collaborative" if the answer was "myself and the doc-
tor alone" or "the doctor, myself and my family equally".
Patient desire for family involvement was classified into
two categories: "wish" if the answer to Question E was "the
doctor and my family alone" or "myself and my family
alone" or "the doctor, myself and my family equally"; and
"do not wish" if the answer was "myself alone" or "the
doctor alone" or "myself and the doctor alone". Nominal
variables were analyzed using the chi-square test or
Fisher's exact test. ANCOVA was performed to identify
variables associated with the patient's preferred role in
decision making and the patient's preference for family
involvement in decision-making. All analyses were per-




Of 149 patients who were approached, 134 (90%) agreed
to participate in the study. One patient refused to con-
tinue in the middle of the interview. There was no statisti-
cal difference in age (P = 0.88) and sex distribution (P =
0.75) between the participants and non-participants. Key
background information is summarized in Table 1. There
were twice as many male (n = 94) as female (n = 39)BMC Family Practice 2004, 5 http://www.biomedcentral.com/1471-2296/5/1
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respondents, reflecting the gender distribution of outpa-
tients at the clinic. The mean age of male respondents was
lower than that of female respondents (56.8 ± 11.3 vs.
60.9 ± 10.0, P = 0.06). The proportion who were
employed was significantly higher in male than in female
respondents (84% vs. 46%, P = 0.0001), as was the mean
years of schooling (14.0 ± 2.7 vs. 12.4 ± 2.4, P = 0.001).
Most of the respondents (93%) lived with other family
members. The numbers of respondents who responded to
the pneumonia, gangrene and cancer vignette were 52, 37
and 44, respectively. No difference was observed in the
distribution of age (P = 0.56), sex (P = 0.63), marital status
(P = 0.21) and employment status (P = 0.15) in the three
vignette subject groups.
Knowledge of treatment options and desire for 
information
Table 2 shows the mean scores and percentages for each
questionnaire item (except A) for each of the three
vignettes. All respondents but one in the pneumonia
vignette group replied to Question A that they would con-
sult a doctor. More than 90% of respondents for each
vignette said they had little or no knowledge of the treat-
ment options, and there was no statistically significant
difference between the three vignettes as regards expressed
desire for information, except as regards the wish to be
given the name of a famous specialist in the disease area
concerned, which was significantly higher in the cancer
vignette group.
All respondents except one expressed a preference to be
informed directly by a doctor, and about two thirds would
wish to share the information with their family members.
Respondents who were allocated the cancer vignette were
more likely to indicate a wish to share the information
with their families than were those allocated the pneumo-
nia vignette (82% vs. 52%, P = 0.003).
Preference for participation in medical decision making
A majority of the respondents for each vignette (68% to
75%) expressed a preference for making treatment deci-
sions in collaboration with a physician. Only 16% (22 of
133 respondents) expressed a preference for delegating
decision-making to their families or to the physician
alone. The proportion of patients who expressed a prefer-
ence for decision-making without involving the physician
was small – 16% for each of the pneumonia and gangrene
vignettes, and 7% for the cancer vignette. Considerably
more expressed a preference for involving their families
[42% for the pneumonia vignette, 41% for the gangrene
vignette, and 70% for the cancer vignette]. The type of
vignette was significantly associated with the patient's
indicated preference for family involvement (χ2 = 9.9, P =
0.007), but not with the patient's preferred role (χ2 = 4.7,
P = 0.32).
Multivariate analyses (ANCOVA) revealed that, after con-
trolling for type of vignette, age and education were signif-
icantly associated with patient preference for decision-
making (Partial r2 = 0.03, P = 0.025 for age; Partial r2 =
0.08, P = 0.001 for education). Older and less-educated
patients were less likely to want to participate in decision
making. Upon adjusting for type of vignette, education
was also significantly associated with patients' preferences
for family involvement (Partial r2 = 0.04, P = 0.03). Age
and gender, however, were not associated with patients'
preferences for family involvement.
The relationship between the patient's expressed role pref-
erence and desire for information is shown in Table 3.
Patients who indicated a preference for a passive role were
less likely to want information concerning treatment
options, risks and benefits, and outcome probabilities,
and were more likely to want to rely on the physician's
recommendations, compared with those who preferred
other roles. About 80% of the respondents would have
sought the involvement of their spouses, and more than a
half the involvement of their children.
Who should have the final decision, in the face of 
disagreement?
About 60% of the respondents for each vignette chose to
respect the physician's recommendation when it con-
flicted with their own preference; while for 30% their own
preference remained paramount (Table 2). Very few
respondents would give the family's opinion primary
sway. Of the 16 respondents who would wish to decide
alone or with their family members (Question E), five
nevertheless answered that they would give their prefer-
ence to a physician's opinion rather than their own, in the
face of disagreement. Vignette had little influence on the
choice of final decision-maker (P = 0.71), but preferred
patient role showed a significant association (Table 4).
Respondents who preferred an active role were more
likely to prefer to make the final decision themselves,
rather than have it made by the physician.
About 60% of the respondents for each vignette consid-
ered that no one should be held responsible for an adverse
outcome of the treatment decided on, when it was appro-
priately performed, and less than 10% considered the
physician should be held responsible (Table 2). The per-
centage who considered that the doctor should be held
responsible did not differ for the three vignettes. More
than 30% of those who preferred an active role considered
that they themselves should be held responsible for the
outcome of their treatment, while only about 10% of
those who preferred other roles held this view.BMC Family Practice 2004, 5 http://www.biomedcentral.com/1471-2296/5/1
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Discussion
Our primary question was whether Japanese patients are
in fact passive as regards medical decision making. Cur-
rent opinion is split over the level of patients' desire for
self-determination and autonomy in Japan. Some argue
that patient self-determination is not compatible with
social mores in Japan, where collective decision-making is
prevalent, and that patients are not accustomed to self-
determination [21,22].
On the other hand, others are dissatisfied with the current
physician paternalism and assert the patient's right to self-
determination. A few years ago, a book entitled "At last I
have caught a good doctor" became a much-discussed
topic in the Japanese media [23]. The book describes the
success story of a patient with a non-ruptured cerebral
aneurysm, who refused the treatment of an arrogant and
paternalistic surgeon, and found another surgeon whom
she judged trustworthy. In order to find a good doctor, she
made use of every available source of information, includ-
ing electronic resources and cooperative friends, and
interviewed several neurosurgeons. Her experiences
aroused a sympathetic response in many readers who
were tired of physician paternalism in Japan.
Japan has a long tradition of physician paternalism [24] as
also seen in many other countries [25-27]. Ishiwata sug-
gested that two deeply seated factors are major contribu-
tors to the paternalism of Japanese physician – an absence
of the spirit of informed consent on the physician's side,
and the practice of omakase (entrusting one's care to one's
family and physician, on the assumption that they will
make the decisions most beneficial or appropriate to one-
self) on the patient's side [28]. As he put it, "Given the
strong paternalism, patient passivity, and the exclusive-
ness among medical professionals in Japan, there is
scarcely any opportunity for patients to participate in
medical decision making." Others attribute physician
paternalism to Japanese behavioral traits, religious beliefs,
and their trust in nature. Morioka [29] and Kitao [30] con-
cluded that the prevalent "mentality of individuals willing
to entrust themselves to another person or to nature" and
"the lack of self-consciousness regarding life and death,"
explain (at least partly) patient passivity as an aspect of
the Japanese cultural tradition.
However the present study found that, compared with the
United States, Canada, Israel and Russia [7,20], there was
no clear evidence that Japanese patients prefer more pas-
sive roles than do their counterparts in Western countries.
A large majority of patients (75% for the cancer vignette,
and almost 90% for the non-cancer vignettes) held posi-
tive attitudes towards participation in medical decision-
making, provided they received adequate information for
the making of decisions.
Previous studies have suggested that patients do not want
to make decisions on their own, although they do like to
participate in determining the final decision. Benbassat,
after reviewing published surveys of patients' preferences
for participation in treatment decision making, concluded
that, "Most respondents did not want an active role, but
neither did they want to be entirely passive in the doctor-
patient relationship [20]." Similarly, Strull et al. con-
cluded that "patients prefer that decisions be made princi-
pally by their physicians, not themselves, although they
very much want to be informed [9]." Katz has defined this
apparently deceptive and incoherent attitude of patients
as 'psychological autonomy', implying the motivation to
become informed in order to exercise, or not, the right to
self determination [16]. Even if armed with information,
some patients may choose to express their autonomy by
authorizing their physicians to make all the decisions, i.e.
may decide not to decide. Although two-thirds of the sub-
jects answered that they would prioritize their physician's
judgment in the case of disagreement, the proportion of
those who answered that "the doctor is responsible for the
outcome of the selected treatment" was limited (ranged
from 5% to 14% across the vignettes). A few subjects
expressed that, "I, myself, am responsible for my treat-
ment outcome, for I am who decides whether to follow
my physician's advice." This statement also implies that
the scope of "decision-making," understood by patients,
carries a broad meaning. It not only denotes the act of
deciding one's medical treatment but also connotes the
act of judging whose opinion is the most beneficial for the
patient.
In our study, the proportion of patients who preferred
active roles ranged from 7% to 16% across the three
vignettes. Nevertheless, a substantial number of patients
considered their opinion to be most important in the final
decision. Two thirds of respondents who preferred an
active role and one third of those who preferred a collab-
orative role regarded themselves as the final decision-
makers when their opinions conflicted with those of their
physicians. This finding suggests a conflict between the
ethical principles of autonomy and beneficence: the pater-
nalistic physician attempts to impose a medically benefi-
cent management strategy on a patient who would, if
adequately consulted, prefer to exercise some autonomy
in the decisions made [31]. There is a possibility that one
third of our study subjects fit this model.
Our second question concerned the factors that affect the
patient's desire for decision participation. Our results
indicated that, as in previous studies, older age and poor
education were significantly associated with a patient
preference for a passive role [9,32-36]. It is therefore sug-
gested that higher socioeconomic status, as well as capac-
ity to understand complicated medical information, areBMC Family Practice 2004, 5 http://www.biomedcentral.com/1471-2296/5/1
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necessary to give patients the confidence to wish to be
active participants in decision making.
The association between type of disease and patient pref-
erence for autonomy varied considerably with the ques-
tion. Patients with the cancer vignette were more likely to
express a preference for a passive role than those with the
non-cancer vignettes (25% vs. 12%), while the propor-
tions of who preferred a collaborative role did not differ
between the cancer (68%) and non-cancer vignettes
(73%). There are several possible reasons for this differ-
ence. Firstly, the Japanese are not familiar with decision
making in cancer treatment, since traditionally cancer
patients have not been told the truth about their illness.
Cancer is one of the most dreaded diseases in contempo-
rary Japan, and until two decades ago, almost all Japanese,
including physicians and patients, considered cancer dis-
closure out of the question [37]. A growing movement in
support of disclosure over the past 15 years has raised
public awareness of the issue, and data suggest that physi-
cians in Japan have increasingly begun to disclose cancer
diagnoses [38,39], but the majority of physicians adhere
to the policy of non-disclosure of a cancer diagnosis to
patients [40,41]. In our study, patients' desire for informa-
tion was consistently high in all vignettes, and was not sig-
nificantly different in the cancer and the non-cancer
vignettes. This finding raises the question of whether the
Japanese still consider cancer an exceptional disease.
Secondly, in many cases the risks and benefits, and their
trade-offs, for the various options for cancer treatment are
too complicated for patients to fully understand, so that
they are not confident about making difficult decisions.
For example, patients' fear of regret for a bad personal
decision could dispose them to have the decision taken
out their hands. In our study, the only piece of informa-
tion that the cancer vignette respondents were more likely
wish for was the name of 'a famous specialist.' This sug-
gests that in the face of cancer, patients may be more likely
to wish to authorize their physician to make all decisions,
to decide not to decide, and therefore wish to ensure the
best chance of his/her decisions being correct [31].
An interesting finding was that even when the treatment
options are quite simple and understandable, and so the
decisions to be made were less difficult, many respond-
ents still did not wish to make decisions on their own. For
example, as many as 87 percent of the respondents with
the  pneumonia  vignette, which asks for a very simple
choice of one among three alternative treatments, and of
one antipussive drug of two, chose to make their choice
with the physician or to delegate the decision to the phy-
sician. This fact suggests that patients want physician's
advice regardless of the severity of the disease or difficulty
of the medical choice.
Our final study question concerned the role of the family
in medical decision-making. Our study showed that
although many patients wished to involve their families
in decision making, very few would allow their family the
final decision. This finding suggests that patients want
their families to support their decision-making, rather
than to provide a third opinion independent of both
patient and physician. Thus, although we have attempted
to analyze the clinical relationship in Japan as tripartite
(i.e. patient, physician, and family), we have found that it
is better described as bilateral, that is, 'physician' and
'patient plus family'. The character of the Japanese sense
of 'self' may partially account for the fuzzy boundaries
between patient and family. Tamura and Lau have
hypothesized that Japanese culture stresses the intercon-
nectedness of persons, especially within the family, and
thus the 'family self' is the 'basic, inner psychological
organization' of the Japanese, and 'is intimately involved
in the individual sense of "self"'. [42] Markus and
Kitayama also defined the construal of the self in many
non-Western cultures including Japan as "the interde-
pendent construal." This term purports that culture insists
on the fundamental connectedness of human beings
resulting in the other being included within the bounda-
ries of the self [43].
Conceivably, however, the alignment of patient and fam-
ily is in part determined by the fact that in Japan patients
may require the cooperation of their families for the ful-
fillment of their treatment decisions. Japanese inpatient
hospital care is distinguished from that in Western coun-
tries by long hospitalization and continued care by the
family. This practice does not only derive from Japanese
culture and tradition [37,44], but also from premature
social infrastructures such as insufficient support by para-
medical staff, and a lack of manpower and facilities in
Japan's healthcare industry [2]. Although this situation is
gradually changing, Japanese patients know that admis-
sion to a hospital may impose heavy burdens and work-
loads on their families. Therefore, obtaining the family's
consent, their commitment to support and cooperation
with hospital care, is an important consideration for Jap-
anese patients.
Our study revealed that many Japanese patients consider
that to make a decision on medical treatment is to reach
an agreement between the patient, the physician, and the
patient's family. Sometimes, patients' decisions may
reflect a mixture of their own values and those of their
families. In the discussion of treatment options, the
patient's opinion has already been united with that of the
family to create the "patient's preference for a treatment
option". Usually, Japanese patients do not mind that their
opinion is not independent of their families', nor do theyBMC Family Practice 2004, 5 http://www.biomedcentral.com/1471-2296/5/1
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imagine that their interests conflict with those of their
families.
Certain limitations of our study need to be recognized.
Firstly, although we used three different diseases (pneu-
monia, gangrene, and cancer) to manipulate severity of
illness, we did not confirm whether or not subjects accu-
rately shared with us the presumed severity of illness.
However, in aims of presenting subjects with a better pic-
ture of illness severity, we provided information about the
prognosis of each disease such as prospect of recovery and
mortality: pneumonia was explained as a disease that
would be cured with mere bed rest; gangrene was
described with the probability of death following surgery
being 1%; and esophageal cancer was described with a 5-
year survival rate of 15–20%. We believe that vignettes'
severity of illness has a relatively high face-validity. Sec-
ondly, the study population was diabetic patients at a sin-
gle clinic, so our results may not generalize to patients
with other illnesses or in other settings. Diabetes is a dis-
ease that requires the patient's active participation in treat-
ment to control blood glucose and to reduce the chances
of developing sequellae, and most of our subjects were
patients with relatively good compliance with treatment.
Therefore, our study participants may have exhibited a
greater desire for participation in treatment decisions than
is general. We did not have a comparison group to iden-
tify the impact of diabetes on patients' desire for participa-
tion in decision making. However, several studies
elsewhere have suggested that diabetic patients prefer less
involvement in medical decision-making than do healthy
adults or patients with other illness [45-47]. If these
results also apply to the Japanese, it is unlikely that our
study results underestimated patients' desire to participate
in decision making in Japan. Secondly, since our study
subjects were patients cared for by only two physicians,
there may have been a selection bias caused by the partic-
ular physician-patient relationships. We did not investi-
gate differences in the patients' desire for participation by
physician, nor by duration of the illness. Further research
will be necessary to determine whether our study results
generalize to the whole population of Japan.
Conclusions
In summary, Japanese patients have positive attitudes
towards participation in medical decision-making, pro-
vided they are fully informed of the nature of the disease,
the treatment options, and the risks and benefits of the
options. Physicians can encourage their participation by
providing adequate medical information, as well as by
supporting their decision-making, using their medical
expertise and their knowledge of the patient's values. The
family's involvement in medical decision making has
important implications for Japanese patients, especially in
cases of severe disease, since the Japanese system counts
on continued patient care by the family. Physicians can
increase patient satisfaction by accepting the role of help-
ing their patients participate in decision-making and
understanding their patients' wishes for family involve-
ment, and so cultivating a democratic relationship in
which decisions can be made cooperatively.
Appendix
Questionnaire
One of the following three vignettes was presented to each
subject. The interviewer asked the subjects to select the
number indicating the best management they feel about
each statement if they actually had the medical condition.
Pneumonia vignette
You have had a productive cough for the past 5 days. You
were well until a week ago, when you began to feel
fatigued and feverish. The cough worsened, and now you
are coughing up greenish brown sputum. The cough kept
you up at last night.
There are three options for treatment: (1) Drug A is expen-
sive, but has strong effects and requires minimal time for
recovery; (2) Drug B is low-priced, but less effective and
requires longer time for recovery than drug A; (3) Bed rest
without medication can also cure the disease but takes at
least 2 weeks. There are two options for cough suppres-
sant: a very strong powder with more side effects, or a
more mildly effective tablet with fewer side effects.
Gangrene vignette
After a penetrating foot injury, a few days ago your right
foot began swelling and draining pus that smells bad. The
painful foot keeps you up all night. You have had a high
fever for the past 3 days.
One of the treatment options is to amputate your leg
beneath the knee. Amputation is a relatively safety proce-
dure, and the probability of death following surgery is
1%. Another option is treatment with antibiotics. If the
antibiotic is effective, amputation will not be necessary
(in 30% of cases). However, if the antibiotic is not effec-
tive, the infection will be extended, and you must have
your leg amputated above the knee. In that case, the
chance of death after surgery is 10%.
Cancer vignette
You have trouble swallowing. You were well until a few
months ago, when you began to feel mid-chest discom-
fort. The discomfort gradually worsened, and now you
cannot swallow solid foods such as rice and meat. You
have lost 5 Kg.
You have been diagnosed with resectable esophageal can-
cer. The 5 year survival rate for this stage of the disease isBMC Family Practice 2004, 5 http://www.biomedcentral.com/1471-2296/5/1
Page 8 of 10
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15–20%. Surgery is the standard approach and can help-
ful for many reasons. In some cases, it can cure the cancer.
It can also relieve the symptoms of the cancer. The death
rate following surgery has decreased in the past 10 years
and is well below 10%. Surgery combined with chemo-
radiation can help to ease symptoms and extend or
improve the quality of life. Chemo-radiation uses anti-
cancer drugs along with radiation to kill the cancer. Anti-
cancer drugs can have some side effects, depending on the
type of drug, how much you take, and how long you take
it. It is very common for patients to develop other health
problems as a result of chemo-radiation, and the chance
of dying from the therapy is as high as 15%.
A. Do you want to consult a doctor immediately?
1. Yes
2. No
B. Given clinical diagnosis for the symptom, do you know
what the treatment options are?




C. The information is enormous and difficult to under-
stand. However, your doctor is willing to explain anything
you want to know. Regarding the treatment options, what
kind of information do you require? (1=Not at all; 2=Par-
tially; 3=I want to know everything)
C-1. Treatment options: 1, 2, 3
C-2. Risks (adverse effects) and benefits of each treatment:
1, 2, 3
C-3. How likely each of these risks and benefits are to hap-
pen (outcome probabilities): 1, 2, 3
C-4. The name of a famous specialist in this particular
field: 1, 2, 3
C-5. Prognosis: 1, 2, 3
C-6. Which treatment option the doctor thinks is the best
(physician's recommendation): 1, 2, 3
D. Who should receive the information you selected
above?
1. Myself alone
2. The doctor should tell me, and also let me decide which
information my family should be given
3. The doctor should tell me and my family equally
4. The doctor should tell my family, and also let them
decide which information I should be told
5. My family alone
E. Given all the information about risks and benefits of
these possible treatments, who should decide the treat-
ment?
1. Myself alone
2. Myself and my family alone
3. Myself and the doctor alone
4. The doctor, myself and my family equally
5. The doctor and my family alone
6. The doctor alone
7. Others
F. If the doctor's recommendation is different from your
preference, whose opinion do you think is most impor-






G. If the treatment which had been chosen and performed
appropriately did not work as expected, who shall be
responsible for this result?
1. Myself
2. The doctor
3. Someone who made decision
4. No one is responsible for itBMC Family Practice 2004, 5 http://www.biomedcentral.com/1471-2296/5/1
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